Alemtuzumab induces changes in the innate immune system in patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Ladwig, A. [1 ]
Suh, J. [1 ]
Schweitzer, F. [1 ]
Roeth, P. [1 ]
Remke, G. [1 ]
Warnke, C. [1 ]
Schroeter, M. [1 ]
Izquierdo-Alvarez, E. [1 ]
Bonmann, E. [2 ]
Fink, G. R. [1 ]
Pallasch, C. [1 ]
Lehmann, H. [1 ]
机构：
[1] Univ Hosp Cologne, Cologne, Germany
[2] Merheim Hosp, Cologne, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0287
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [31] Influence of Alemtuzumab Treatment on Peripheral Mediators of Inflammation in Relapsing-Remitting Multiple Sclerosis Patients
    Studer, Valeria
    Ferri, Anna
    Perugini, Jacopo
    Clerici, Valentina Torri
    Confalonieri, Paolo
    Antozzi, Carlo
    Mantegazza, Renato
    Schilke, Edoardo
    Brambilla, Laura
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 25 - 26
  • [32] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [33] Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
    Frank Riemer
    Ellen Skorve
    Ofer Pasternak
    Fulvio Zaccagna
    Astri J. Lundervold
    Øivind Torkildsen
    Kjell-Morten Myhr
    Renate Grüner
    Communications Medicine, 3
  • [34] Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
    Riemer, Frank
    Skorve, Ellen
    Pasternak, Ofer
    Zaccagna, Fulvio
    Lundervold, Astri J.
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    Gruner, Renate
    COMMUNICATIONS MEDICINE, 2023, 3 (01):
  • [35] Neurocognitive changes in patients with relapsing-remitting multiple sclerosis treated with natalizumab
    Doehler, N.
    Mueller, S.
    Vehoff, J.
    Galovic, M.
    Tettenborn, B.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 213 - 213
  • [36] Miscarriage induces reactivation of inflammation in relapsing-remitting multiple sclerosis
    Landi, D.
    Cortese, A.
    Martinelli, C.
    Fantozzi, R.
    Pontecorvo, S.
    Prosperini, L.
    Mataluni, G.
    Millefiorini, E.
    Francia, A.
    Pozzilli, C.
    Boffa, L.
    Centonze, D.
    Marfia, G. A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 114 - 115
  • [37] Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
    Penkert, Horst
    Delbridge, Claire
    Wantia, Nina
    Wiestler, Benedikt
    Korn, Thomas
    JAMA NEUROLOGY, 2016, 73 (06) : 757 - 759
  • [38] Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis
    Landi, Doriana
    Ragonese, Paolo
    Prosperini, Luca
    Nociti, Viviana
    Haggiag, Shalom
    Cortese, Antonio
    Fantozzi, Roberta
    Pontecorvo, Simona
    Ferraro, Elisabetta
    Buscarinu, Maria Chiara
    Mataluni, Giorgia
    Monteleone, Fabrizia
    Salvetti, Marco
    Di Battista, Giancarlo
    Francia, Ada
    Millefiorini, Enrico
    Gasperini, Claudio
    Mirabella, Massimiliano
    Salemi, Giuseppe
    Boffa, Laura
    Pozzilli, Carlo
    Centonze, Diego
    Marfia, Girolama Alessandra
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (12): : 1272 - 1278
  • [39] A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Cuker, Adam
    Coles, Alasdair J.
    Sullivan, Herman
    Fox, Edward
    Goldberg, Mark
    Oyuela, Pedro
    Purvis, Annie
    Beardsley, Diana S.
    Margolin, David H.
    BLOOD, 2011, 118 (24) : 6299 - 6305
  • [40] Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis
    María Rosario Blasco
    Antonio Ramos
    Celia García Malo
    Antonio García-Merino
    Journal of Neurology, 2017, 264 : 168 - 169
12345